
RadNet, Inc.
RDNTNASDAQHealthcareMedical - Diagnostics & Research
Latest quote
$76.77
−$0.23 · -0.30%
RDNT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
53
Fair Value
Momentum
45
Neutral
Sentiment
56
Mixed
Risk resilience
51
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteRadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Howard G. Berger
- Listed since
- Jan 3, 1997
- Employees
- 9,060
Market position
- Volume
- 644.95K
- 0.76× average
- Average volume
- 853.34K
- Average daily volume
- Market cap
- 6.04B USD
- Beta
- 1.38
- Market reference 1
RDNT peers
ETFs holding RDNT
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR327.02M0.29%111.19B USD0.06%$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI144.24M0.01%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM139.33M0.17%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB103.78M0.06%183.4B USD0.03%$304.76+0.64%
Defiance Quantum ETFQTUM86.81M1.54%——$150.47+0.85%
Vanguard Morningstar Small-Cap Growth ETFVBK60.11M0.13%43.8B USD0.05%$358.65+0.70%
Vanguard Extended Market ETFVXF52M0.05%93.7B USD0.05%$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM51.2M0.30%17.03B USD0.03%$57.28+0.61%
iShares Core S&P Small-Cap ETFIJR- Market value
- 327.02M
- Weight
- 0.29%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 144.24M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 139.33M
- Weight
- 0.17%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 103.78M
- Weight
- 0.06%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Defiance Quantum ETFQTUM- Market value
- 86.81M
- Weight
- 1.54%
- AUM
- —
- Expense ratio
- —
- Price / 1D
- $150.47+0.85%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 60.11M
- Weight
- 0.13%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
Vanguard Extended Market ETFVXF- Market value
- 52M
- Weight
- 0.05%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 51.2M
- Weight
- 0.30%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $57.28+0.61%
Continue in GoAI
Research RDNTresearch.disclaimer





